|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM209525150 |
003 |
DE-627 |
005 |
20231224005936.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2011 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/jcc.21857
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0698.xml
|
035 |
|
|
|a (DE-627)NLM209525150
|
035 |
|
|
|a (NLM)21710635
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Ozawa, Tomonaga
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Importance of CH/π hydrogen bonds in recognition of the core motif in proline-recognition domains
|b an ab initio fragment molecular orbital study
|
264 |
|
1 |
|c 2011
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 08.11.2011
|
500 |
|
|
|a Date Revised 21.11.2013
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2011 Wiley Periodicals, Inc.
|
520 |
|
|
|a We examined CH/π hydrogen bonds in protein/ligand complexes involving at least one proline residue using the ab initio fragment molecular orbital (FMO) method and the program CHPI. FMO calculations were carried out at the Hartree-Fock (HF)/6-31G*, HF/6-31G**, second-order Møller-Plesset perturbation (MP2)/6-31G*, and MP2/6-31G** levels for three Src homology 3 (SH3) domains and five proline-recognition domains (PRDs) complexed with their corresponding ligand peptides. PRDs use a conserved set of aromatic residues to recognize proline-rich sequences of specific ligands. Many CH/π hydrogen bonds were identified in these complexes. CH/π hydrogen bonds occurred, in particular, in the central part of the proline-rich motifs. Our results suggest that CH/π hydrogen bonds are important in the recognition of SH3 and PRDs by their ligand peptides and play a vital role in the signal transduction system. Combined use of the FMO method and CHPI analysis is a valuable tool for the study of protein/protein and protein/ligand interactions and may be useful in rational drug design
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Ligands
|2 NLM
|
650 |
|
7 |
|a Peptides
|2 NLM
|
650 |
|
7 |
|a Proteins
|2 NLM
|
650 |
|
7 |
|a Proline
|2 NLM
|
650 |
|
7 |
|a 9DLQ4CIU6V
|2 NLM
|
700 |
1 |
|
|a Okazaki, Kosuke
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kitaura, Kazuo
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Journal of computational chemistry
|d 1984
|g 32(2011), 13 vom: 15. Okt., Seite 2774-82
|w (DE-627)NLM098138448
|x 1096-987X
|7 nnns
|
773 |
1 |
8 |
|g volume:32
|g year:2011
|g number:13
|g day:15
|g month:10
|g pages:2774-82
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/jcc.21857
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 32
|j 2011
|e 13
|b 15
|c 10
|h 2774-82
|